Landscapes / Targets
complement C3
4 drugs act on complement C3, in 11 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs4
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Complement inhibitor |
Approved | Jul 2027Phase 3 trial completes | |||
| How it works | Blocks part of the complement system | ||||
| Next date | Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Paroxysmal Nocturnal Hemoglobinuria (PNH) and 16 more | ||||
| Open drug page | |||||
— |
Phase 2 | Feb 2028Phase 2 trial completes | |||
| Next date | Feb 2028 · Phase 2 trial completes | ||||
| Also tested for | IgA Nephropathy, Lupus Nephritis (LN) and 1 more | ||||
| Open drug page | |||||
— |
Phase 2 | 10 Aug 2028Phase 2 trial completes | |||
| Next date | 10 Aug 2028 · Phase 2 trial completes | ||||
| Also tested for | IgAN - IgA Nephropathy, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Mar 2029Phase 2 trial completes | |||
| Next date | 31 Mar 2029 · Phase 2 trial completes | ||||
| Also tested for | IgA Nephropathy (IgAN), Renal Impairments and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 4 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026